Federal contract award
75N94023F00001
OVAPRENE PHASE 1- PROTOCOLFINALIZATION, REGULATORY APPROVAL,START-UP, AND COMMENCEMENT OF RECRUITMENT,SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N94020D00012 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $69.1K |
| Current contract value | $69.1K |
| Potential contract value / ceiling | $69.1K |
| Start date | Sep 28, 2023 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | May 30, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 30, 2025 | P00005 | $5.3K | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| May 1, 2025 | P00004 | $0 | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| Mar 17, 2025 | P00003 | $0 | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.